Some pharmacological obesity treatments, for example, Orlistat, function through specific, irreversible inhibition of gastrointestinal lipases, of which pancreatic lipase is the most biologically active and important one in healthy humans [41]. Here, PNLIP is linked to obesity due to melanocortin 4 receptor deficiency.